Wells Fargo’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-40,480
| Closed | -$5.67M | – | 6732 |
|
|
2018
Q4 | $5.67M | Buy |
40,480
+19,959
| +97% | +$3.03M | ﹤0.01% | 2323 |
|
|
2018
Q3 | $3.51M | Buy |
20,521
+5,916
| +41% | +$994K | ﹤0.01% | 2949 |
|
|
2018
Q2 | $2.53M | Sell |
14,605
-1,533
| -9% | -$230K | ﹤0.01% | 3267 |
|
|
2018
Q1 | $1.86M | Buy |
16,138
+428
| +3% | +$45.5K | ﹤0.01% | 3444 |
|
|
2017
Q4 | $1.32M | Sell |
15,710
-2,318
| -13% | -$193K | ﹤0.01% | 3719 |
|
|
2017
Q3 | $1.66M | Buy |
18,028
+1,933
| +12% | +$150K | ﹤0.01% | 3449 |
|
|
2017
Q2 | $1.29M | Buy |
16,095
+592
| +4% | +$32.8K | ﹤0.01% | 3535 |
|
|
2017
Q1 | $653K | Buy |
15,503
+3,875
| +33% | +$160K | ﹤0.01% | 4069 |
|
|
2016
Q4 | $373K | Buy |
11,628
+5,044
| +77% | +$129K | ﹤0.01% | 4399 |
|
|
2016
Q3 | $172K | Buy |
6,584
+1,874
| +40% | +$49K | ﹤0.01% | 4567 |
|
|
2016
Q2 | $109K | Sell |
4,710
-174
| -4% | -$4.33K | ﹤0.01% | 4774 |
|
|
2016
Q1 | $133K | Buy |
4,884
+143
| +3% | +$2.99K | ﹤0.01% | 4651 |
|
|
2015
Q4 | $134K | Buy |
4,741
+3,709
| +359% | +$99.5K | ﹤0.01% | 4715 |
|
|
2015
Q3 | $18K | Sell |
1,032
-358
| -26% | -$7K | ﹤0.01% | 5578 |
|
|
2015
Q2 | $25K | Buy |
1,390
+218
| +19% | +$2.98K | ﹤0.01% | 5539 |
|
|
2015
Q1 | $14K | Buy |
1,172
+1,004
| +598% | +$12.5K | ﹤0.01% | 5515 |
|
|
2014
Q4 | $2K | Buy |
+168
| New | +$1.96K | ﹤0.01% | 6042 |
|
Other funds holding LOXO
Wells Fargo's LOXO Position: Q1 2019 in Review
Wells Fargo sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 40,480 shares — an estimated $5.67M sold.
Wells Fargo first reported a position in LOXO in Q4 2014 and held it in 17 quarters. The position peaked at $5.67M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Wells Fargo reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Wells Fargo sold 40,480 Loxo Oncology, Inc shares in Q1 2019, an estimated $5.67M.
- Wells Fargo first reported a position in Loxo Oncology, Inc in Q4 2014 and held it in 17 quarters.
- Wells Fargo's Loxo Oncology, Inc position peaked at $5.67M in Q4 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Wells Fargo's 13F filing for Q1 2019, filed 10 May 2019.